JPRN-UMIN000014000已完成未知
Verifying the control effects of glucose absorption through the comparison of SekirenB2 with a placebo in double blind cross over comparative study. - PRT-AD-MF-OGTT-SEKIREN-01-01
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)A person who is suspected to have an impaired liver function on result of clinical laboratory test at the screening. a) T-Bil 3.0 or more b) GOT,GPT More than normalcy upper limit multiply 2.5(100 or more) c) A1-P More than normalcy upper limit multiply 2.5 d) gamma-GTP More than normalcy upper limit multiply 1.5 e) LDH More than normalcy upper limit multiply 1.5 2)A person who has disease of gastrointestinal tract, kidney and the heart which have an influence on absorption, distribution, metabolism and the excretion. 3)A person who has surgical history of gastrointestinal tract site. For example gastrectomy, stomach and intestines suture, intestinal tract resection and so on. 4)A person who has food allergy. 5)A person who has alcohol or drug dependence. 6)A person who treated diabetes within 3 months at the time of obtaining informed consent. 7)A person who participated in other clinical study of new drug or received medical treatment within 3 months at the time of obtaining informed consent. 8)A person who take other medicine from less than one week to start this clinical trial. 9)A person who has taken the whole blood bleeds or ingredient blood collecting (plasma or plaque component blood collecting) more than 200ml within 3 months at the time of obtaining informed consent or during the period between the time of obtaining informed consent and this clinical trial implementation. 10)A person who can't obey management manner or can't report about subjective symptoms during participation in clinical trials. 11)In addition a person who is identified as improper by the responsibility researcher or subresponsibility researcher. 12)A woman who is pregnant or breastfeeding.
研究者
相似试验
已完成
Unknown
Verifying the control effects of glucose absorption through the comparison of SekirenB2 with a placebo in double blind cross over comparative study.1)HbA1c: 6.4% or less2)HbA1c: 6.5% or more and less than 7.0%JPRN-jRCT1091220179ADAPTGEN PHARMACEUTICAL CO.,LTD.20
招募中
不适用
Observational study of efficacy of glucose level in saliva as a marker of blood sugar in perioperative or diabetic patients1.diabetes mellitus 2.intracranial vessel diseaseJPRN-UMIN000010920Fukuoka University Department of Anesthesiology40
已完成
不适用
Evaluation of blood glucose response after intake of heat-moisture treated brown rice flour cracker.AdultJPRN-UMIN000035168iigata Bio-Research Park , Inc12
尚未招募
3 期
Comparison of efficacy and safety of different doses of metformin in women with gestational diabetes mellitusCTRI/2023/11/059803All India Institute of Medical Sciences New Delhi
已完成
不适用
Investigation for monitoring of the glucose concentration in the aqueous humorHealthy adult volunteerJPRN-UMIN000021083Keio University School of Medicine3